原发性醛固酮增多症患者的高血压危险度分层及心脑血管合并症:北京阜外心血管病医院调查

被引：14

作者：

李彬

蒋雄京

彭猛

董徽

车武强

邹玉宝

张慧敏

宋雷

刘亚欣

卞瑾

周宪梁

吴海英

机构：

[1] 北京协和医学院,中国医学科学院,阜外心血管病医院心内科

来源：

中华高血压杂志 | 2015年 / 23卷 / 07期

关键词：

原发性醛固酮增多症; 高血压危险度分层; 心脑血管合并症;

D O I：

10.16439/j.cnki.1673-7245.2015.07.018

中图分类号：

R586.24 [];

学科分类号：

摘要：

目的调查原发性醛固酮增多症(PA)患者的高血压危险度分层及心脑血管合并症的检出率。方法采用回顾性研究方法,连续入选2010年3月-2014年3月于北京阜外心血管病医院高血压中心初次住院治疗的PA患者195例,调查其高血压危险度分层及心脑血管合并症[冠状动脉性心脏病(冠心病)、充血性心力衰竭、心房颤动及脑卒中]检出率,比较伴或不伴心脑血管合并症患者的临床特征。结果 PA患者中高血压危险分层为高危或很高危占83.6%(163/195)。PA患者中心脑血管合并症总检出率为26.2%(51/195),其中冠心病、充血性心力衰竭、心房颤动及脑卒中的检出率分别为13.3%(26/195)、2.6%(5/195)、3.6%(7/195)、9.2%(18/195)。PA伴心脑血管合并症患者的年龄、病程、体质量指数、血清尿素氮和肌酐值以及血脂异常、糖尿病比例显著大于PA不伴心脑血管合并症患者(均P<0.05)。结论 PA患者高血压危险度分层多为高危或很高危,心脑血管合并症总检出率不容忽视。提示早期诊断和病因治疗十分重要。

引用

页码：644 / 648

页数：5

共 17 条

[1]

Primary aldosteronism in hypertensive patients: clinical implications and target therapy [J].

Papanastasiou, Labrini ;

Markou, Athina ;

Pappa, Theodora ;

Gouli, Aggeliki ;

Tsounas, Panagiotis ;

Fountoulakis, Stelios ;

Kounadi, Theodora ;

Tsiama, Vasiliki ;

Dasou, Aikaterini ;

Gryparis, Alexandros ;

Samara, Christianna ;

Zografos, George ;

Kaltsas, Gregory ;

Chrousos, George ;

Piaditis, George .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (08) :697-706

[2]

Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study [J].

Savard, Sebastien ;

Amar, Laurence ;

Plouin, Pierre-Francois ;

Steichen, Olivier .

HYPERTENSION, 2013, 62 (02) :331-336

[3]

Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn's Registry [J].

Born-Frontsberg, E. ;

Reincke, M. ;

Rump, L. C. ;

Hahner, S. ;

Diederich, S. ;

Lorenz, R. ;

Allolio, B. ;

Seufert, J. ;

Schirpenbach, C. ;

Beuschlein, F. ;

Bidlingmaier, M. ;

Endres, S. ;

Quinkler, M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) :1125-1130

[4]

Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline [J].

Funder, John W. ;

Carey, Robert M. ;

Fardella, Carlos ;

Gomez-Sanchez, Celso E. ;

Mantero, Franco ;

Stowasser, Michael ;

Young, William F., Jr. ;

Montori, Victor M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) :3266-3281

[5]

Increased intima–media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension.[J]..Journal of Hypertension.2007, 7

[6]

Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension [J].

Strauch, Branislav ;

Petrak, Ondrej ;

Wichterle, Dan ;

Zelinka, Tomas ;

Holaj, Robert ;

Widimsky, Jiri, Jr. .

AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (09) :909-914

[7]

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [J].

Milliez, P ;

Girerd, X ;

Plouin, PF ;

Blacher, J ;

Safar, ME ;

Mourad, JJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1243-1248

[8]

Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension.[J].David A. Calhoun;Mari K. Nishizaka;Mohammad A. Zaman;Roopal B. Thakkar;Paula Weissmann.Hypertension: Journal of the American Heart Association.2002, 6

[9]

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [J].

Lewington, S ;

Clarke, R ;

Qizilbash, N ;

Peto, R ;

Collins, R .

LANCET, 2002, 360 (9349) :1903-1913

[10]

Conn's syndrome and atrial fibrillation [J].

Porodko, M ;

Auer, J ;

Eber, B .

LANCET, 2001, 357 (9264) :1293-1294

← 1 2 →